Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × antineoplaston A10 × Clear all

Sponsor

Conditions

Astrocytoma 8 Glioblastoma 5 Neuroectodermal Tumors, Primitive 3 Neurocytoma 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Brain Neoplasms 2 Rhabdoid Tumor 1 Recurrence 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms, Unknown Primary 1 Mesothelioma, Malignant 1 Meningioma 1 Gliosarcoma 1 Ganglioglioma 1 Esophageal Neoplasms 1 Ependymoma 1 Craniopharyngioma 1 Adrenocortical Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡